SANGAMO THERAPEUTICS, INC — Form 8-K
Filed July 1, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 98/100
What the filing says
Sangamo Therapeutics, Inc. filed a voluntary Chapter 11 bankruptcy petition (Case No. 26-10989) on June 24, 2026. The company's stock was delisted from Nasdaq on April 28, 2026 due to failure to meet minimum bid price requirements, began trading on OTCQB on May 5, 2026, and moved to OTCID Basic Market under symbol 'SGMOQ' on June 24, 2026. On June 25, 2026, Ernst & Young was terminated as the independent auditor; no material disagreements or reportable events were noted in prior audits.
Why this rating
Bankruptcy is an existential event; company's $152.7M market cap is now in liquidation/restructuring. Stock delisting and OTC trading reflect total loss of confidence.
Extracted items
View original filing on SEC.gov ↗
See more from July 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.